Inhibition by retinoic acid of myeloid progenitors in chronic myeloid leukemia and myeloproliferative disease: increased sensitivity in blastic phase of chronic myeloid leukemia

This publication has 21 references indexed in Scilit:

• Disappearance of cytogenetic abnormalities and clinical remission during therapy with 13-cis-retinoic acid in a patient with myelodysplastic syndrome: inhibition of growth of the patient's malignant monocytoid clone
  Blood, 1986
• 13-cis retinoic acid treatment for myelodysplastic syndromes.
  Journal of Clinical Oncology, 1986
• Retinoic acid as antileukemic therapy in a patient with acute promyelocytic leukemia and Aspergillus pneumonia
  Blood, 1986
• The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia
  Cancer, 1986
• 13-cis-Retinoic acid does not increase the true remission rate and the duration of true remission (induced by cytotoxic chemotherapy) in patients with chronic phase chronic myelogenous leukemia.
  Journal of Clinical Oncology, 1985
• In-vitro effect of retinoic acid on normal and chronic myeloid leukemia granulopoiesis
  Leukemia Research, 1985
• The effect of retinoids on CFU‐GM from normal subjects and patients with myelodysplastic syndrome
  British Journal of Haematology, 1985
• Inhibition of normal human macrophage progenitors by retinoic acid
  British Journal of Haematology, 1984
• Allogeneic bone marrow transplantation as treatment for accelerating chronic myelogenous leukemia
  Blood, 1984
• Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells.
  Journal of Clinical Investigation, 1982